TrialClinical cancer research : an official journal of the American Association for Cancer Research2016

Clinical and Translational Results of a Phase II, Randomized Trial of an Anti-IGF-1R (Cixutumumab) in Women with Breast Cancer That Progressed on Endocrine Therapy.

William J Gradishar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.